A
THRD

AJOVista’s Third Harmonic Bio THRD Stock Holding History

AJOVista’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,747
Closed -$19.2K – 388
2023
Q4 		$19.2K Buy
+1,747
New +$13.8K 0.02% 364

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AJOVista's THRD Position: Q1 2024 in Review

AJOVista sold out of Third Harmonic Bio (THRD) in Q1 2024, closing a stake of 1,747 shares — an estimated $19.2K sold.

AJOVista first reported a position in THRD in Q4 2023 and held it in 1 quarter. The position peaked at $19.2K in Q4 2023. 71 funds tracked by Wall St. Rank hold THRD as of Q1 2024.

  • AJOVista reported no remaining Third Harmonic Bio position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 1,747 Third Harmonic Bio shares in Q1 2024, an estimated $19.2K.
  • AJOVista first reported a position in Third Harmonic Bio in Q4 2023 and held it in 1 quarter.
  • AJOVista's Third Harmonic Bio position peaked at $19.2K in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.